Aesica Pharmaceuticals has today announced (15th December 2010) that it has signed contracts ahead of acquiring three manufacturing sites in Germany andItaly
15 December, 2010
Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, today announced presentations of new data on its combinatorial oncogenic kinase inhibitor AT9283. The presentations will be made during the 52nd American Society of Hematology Meeting, 4-7th December in Orlando.
08 December, 2010
Vitamin D status is linked with increased risk of many chronic diseases including autoimmune diseases, cardiovascular disease, cancers, type II diabetes and infectious diseases. This new awareness of the importance of vitamin D to overall health and the consequences of vitamin D deficiency has stimulated rapid growth in the demand for vitamin D tests at hospitals and clinics. Consequently, antibodies for use in such diagnostic tests are highly sought after within the healthcare industry.
07 December, 2010